Richard J Harlow Jr. MD

Hospital Medicine/Hospitalist

Physician

2301 Holmes StKansas City, MO 64108
Phone+1 816-404-4345

Dr. Harlow is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harlow's full profile Already have an account?

Education & Training

University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1982 - 1985
University of Missouri Kansas City School of MedicineClass of 1982

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 1983 - 2027
FL State Medical License 2019 - 2021
KS State Medical License 1997 - 2021
American Board of Internal Medicine Internal Medicine

Press Mentions

Practical and Scalable Two-Step Process for 6-(2-Fluoro-4-Nitrophenyl)-2-Oxa-6-Azaspiro[3.3]Heptane: A Key Intermediate of the Potent Antibiotic Drug Candidate TBI-223August 2nd, 2023